Published January 2006
| public
Journal Article
Science For Life: A Conversation With Nobel Laureate David Baltimore
- Creators
- Culliton, Barbara J.
-
Baltimore, David
Abstract
As a man with equal interests in science and science policy, David Baltimore has been at the forefront of many of the important debates that have shaped science since the 1970s. Very much engaged in the initial discussions about the use of recombinant DNA technology, Baltimore had a front-row seat as the biotechnology industry developed. He was also a major player in the decision that resulted in funding of the Human Genome Project by the National Institutes of Health (NIH). Baltimore discusses biotechnology, science education, and the need for a strong dialogue among scientists and scholars in the health policy community.
Additional Information
© 2006 Project HOPE—The People-to-People Health Foundation, Inc. This interview is the third in a series of interviews with leaders in the biomedical sector, sponsored by the nonprofit Institute for Health Technology Studies, or In Health, which recognizes that innovation in medical technology plays a vital role in better and more cost effective health care. The series focuses on individuals who are either innovators in their own right or in a position to foster novel research.Additional details
- Eprint ID
- 102828
- DOI
- 10.1377/hlthaff.25.w235
- Resolver ID
- CaltechAUTHORS:20200428-075734432
- Created
-
2020-04-28Created from EPrint's datestamp field
- Updated
-
2021-11-16Created from EPrint's last_modified field